JOHNSON & JOHNSON (Pharmaceutical Preparations)

Pharmaceutical Preparations

Filing Clarity monitors every SEC filing for JOHNSON & JOHNSON — Form 4 insider transactions, 8-K material events, and quarterly reports — and delivers plain-English signals with historical context.

Recent SEC filing signals

Filing Clarity delivers plain-English signals for each new filing, with historical context showing what changed from prior periods.

Earnings SynthesisJOHNSON & JOHNSON Q2-2026: "lead the Investor Relations team moving forward" first appearance — new IR leadership ann…2026-08-17

Earnings SynthesisJOHNSON & JOHNSON Q3-2025: "continued momentum" first appearance since available transcripts2026-08-17

Earnings SynthesisJOHNSON & JOHNSON Q1-2026: "resilience and diversification" increased frequency from Q4-20252026-08-17

Earnings SynthesisJOHNSON & JOHNSON Q2-2026: "portfolio rationalization" first appearance in earnings call context2026-08-17

Ecosystem

Amgen (competitor)Teva (competitor)Alvotech (competitor)Eli Lilly (competitor)AbbVie (competitor)Merck (competitor)

Monitor JNJ with Filing Clarity

Plain-English signals for every JNJ SEC filing. Free during our testing period — no credit card required.

Add JNJ to my watchlist →

What is an 8-K? How to read Form 4 Pricing